Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -340,141 | -246,792 | -162,128 | -78,335 | -306,620 |
| Depreciation Amortization | 11,114 | 8,108 | 5,391 | 2,582 | 9,160 |
| Accounts receivable | 264 | 1,250 | 1,250 | -8,360 | -1,250 |
| Accounts payable and accrued liabilities | 9,067 | 8,710 | 4,356 | 9,555 | -815 |
| Other Working Capital | 52,584 | 11,255 | 2,589 | -2,607 | 63,685 |
| Other Operating Activity | 46,590 | 31,216 | 21,267 | 11,467 | 55,081 |
| Operating Cash Flow | $-220,522 | $-186,253 | $-127,275 | $-65,698 | $-180,759 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 32,838 | 54,696 | 49,646 | 15,696 | -116,215 |
| PPE Investments | -10,580 | -8,114 | -4,258 | -2,197 | -4,513 |
| Investing Cash Flow | $22,258 | $46,582 | $45,388 | $13,499 | $-120,728 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -254 | -192 | -130 | -66 | -389 |
| Common Stock Issued | 105,459 | 53,929 | 6,730 | 4,206 | 429,649 |
| Other Financing Activity | -1,261 | -1,261 | -1,261 | -1,248 | -1,686 |
| Financing Cash Flow | $103,944 | $52,476 | $5,339 | $2,892 | $427,574 |
| Beginning Cash Position | 201,798 | 201,798 | 201,798 | 201,798 | 75,711 |
| End Cash Position | 107,478 | 114,603 | 125,250 | 152,491 | 201,798 |
| Net Cash Flow | $-94,320 | $-87,195 | $-76,548 | $-49,307 | $126,087 |
| Free Cash Flow | |||||
| Operating Cash Flow | -220,522 | -186,253 | -127,275 | -65,698 | -180,759 |
| Capital Expenditure | -10,580 | -8,114 | -4,258 | -2,197 | -4,513 |
| Free Cash Flow | -231,102 | -194,367 | -131,533 | -67,895 | -185,272 |